ImageneBio, Inc. (NASDAQ: IMA) — Healthcare · Share Price, Chart & Market Data
About: ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.71 (-2.56%)
IMAImageneBio, Inc.
Loading watchlist status…
Trade IMA now
ImageneBio, Inc. share price
IMA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:46 am GMT+0
IMA price performance
-4.833%
5D
5.545%
1M
-15.533%
YTD
371.901%
1Y
IMA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:46 am GMT+0
IMA Market Signals